Columbia researchers developed probiotic bacteria that train the immune system to eliminate cancer cells, paving the way for a new class of cancer vaccinations that take advantage of bacteria's innate tumour-targeting abilities. These microbial cancer vaccines can be tailored to each person'
Under this agreement, Sun Pharma will hold exclusive global rights to commercialise Fibromun, while Philogen will continue conducting pivotal clinical trials, pursue marketing authorisation from regulatory bodies, and manufacture the product.
Long-term data from a landmark international trial show that about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors live cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre i
Boston (Massachusetts) [US]/ Bangalore (Karnataka) [India], June 12: Zumutor Biologics Inc. "Zumutor", a Boston-based clinical stage Oncology Company developing first-in-class monoclonal antibody molecules targeting innate immunological pathways, today announced that the first patient was do
Researchers have discovered a possible target for cancer immunotherapy. The research, directed by Professor Massimiliano Mazzone, discovered that the CDA gene is one of the most elevated metabolic genes in immunotherapy-resistant cancer. Inhibiting this gene through pharmacological or geneti
Developing nerve cells outside the brain is where neuroblastoma, a common childhood disease, starts. Over 40 per cent of patients with high-risk neuroblastoma currently do not survive, despite the fact that patient's chances of survival have increased with more aggressive treatments.
Liver inflammation, a typical side effect of malignancies elsewhere in the body, has long been associated with poor cancer outcomes and, more recently, with poor response to immunotherapy. A team of researchers from the University of Pennsylvania's Abramson Cancer Centre and Perelman School
For the first time in 50 years, a phase 3 randomised, placebo-controlled trial found that an adjuvant therapy improved overall survival in kidney cancer patients.
Bangalore (Karnataka) [India], April 4: In 2022, India faced a challenge, with over 14.1 lakh new cancer cases and more than 9.1 lakh deaths due to the disease. The risk of developing cancer before the age of 75 in India is calculated at 10.6%, with a mortality risk of 7.2%. These numbers
Bengaluru (Karnataka) [India], March 26: The Global Healthcare Academy (GHA) successfully concluded its highly anticipated "Best of ASCO" conference today, marking a significant milestone in advancing cancer care in India and beyond. Over 300+ delegates from across the country participated i
Manipal (Karnataka) [India], February 29: India's first Nature Conference on "Nanomaterials in biomedical applications "in collaboration with Nature Portfolio's leading journals - Nature Communications and Nature Nanotechnology was successfully concluded at Manipal on 27th February 2024. Hos
Researcher Paul Dent of Virginia Commonwealth University's Department of Biochemistry and Molecular Biology found that tumours that have metastasized to distant locations, such as the brain, are most often impossible to treat and cure, despite recent successes in some tumour types such as NS